Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Rite Aid Expanding Free Drive-Thru Coronavirus Testing

By Eric Volkman - Dec 22, 2020 at 4:34PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

99 new locations are to come on line Tuesday.

In partnership with the government's Department of Health and Human Services (HHS), Rite Aid ( RAD 3.17% ) is increasing the number of drive-thru locations where individuals can get free tests for the coronavirus. In a press release, the big pharmacy chain said 99 new locations would begin operations today. These are in 12 states, including New York, Ohio, and California.

Anyone age 13 or older is eligible for the tests, which consist of self-administered nasal swabs. As with the existing locations, the new sites will be staffed by Rite Aid pharmacists and operate from 10 a.m. to 8 p.m. local time on weekdays, and 10 a.m. to 5 p.m. Saturday and Sunday.

Gloved hand holding a swab sample.

Image source: Getty Images.

All patients must fill out a screening form and schedule a time slot via Rite Aid's website. They will also be required to show a government-issued ID. Minors must be accompanied by an adult. 

All told, Rite Aid operates 400 testing sites across 16 states. As with the screening form and scheduling portal, the testing locations are available on the company's website. In its press release, Rite Aid stressed that it "has adequate capacity to test symptomatic and asymptomatic individuals 13 years and older who want to be tested."

In addition to its partnership with HHS, Rite Aid is offering the free testing with the support and collaboration with several companies active in the diagnostics segment, among them OPKO Health's BioReference Laboratories.

Rite Aid has been in the spotlight with healthcare investors recently due to the quite better-than-expected third-quarter results it announced last week. But it seems there is some doubt as to whether that overperformance is sustainable; on Tuesday, the stock fell by 9.3%, well exceeding the 0.2% decline of the S&P 500 index.

 
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Rite Aid Corporation Stock Quote
Rite Aid Corporation
RAD
$12.38 (3.17%) $0.38
OPKO Health, Inc. Stock Quote
OPKO Health, Inc.
OPK
$3.81 (-1.29%) $0.05

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
624%
 
S&P 500 Returns
140%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/07/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.